Notable Facts
→Chief Medical Officer at Oruka Therapeutics since April 2024, leading clinical development of novel psoriasis treatments
→Previously CMO at Cara Therapeutics (2018-2024) where she guided KORSUVA through FDA approval
→20+ years experience in dermatology clinical development including work at Celgene on OTEZLA for psoriasis
→Led medical affairs for multiple successful drug approvals including first oral drug for psoriasis
→Currently overseeing Phase 2 trials for potentially breakthrough psoriasis treatments with once-yearly dosing